Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 54, Issue 3

Issues

Marked elevation of procalcitonin in a patient with a drug related infusion reaction to rituximab

Christoph Robier
  • Corresponding author
  • Central Laboratory, Hospital of the Brothers of St. John of God, Graz, Bergstr. 27, 8020 Graz, Austria
  • Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Manfred Neubauer / Gerhard Reicht
Published Online: 2015-09-19 | DOI: https://doi.org/10.1515/cclm-2015-0772

References

  • 1.

    Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010;375:463–74.Web of ScienceGoogle Scholar

  • 2.

    Meisner M. Update on procalcitonin measurements. Ann Lab Med 2014;34:263–73.CrossrefGoogle Scholar

  • 3.

    Sfia M, Boeckler P, Lipsker D. High procalcitonin levels in patients with severe drug reactions. Arch Dermatol 2007;143:1591.Web of ScienceGoogle Scholar

  • 4.

    Hounoki H, Yamaguchi S, Taki H, Okumura M, Shinoda K, Tobe K. Elevated serum procalcitonin in anaphylaxis. J Antimicrob Chemother 2013;68:1689–90.Web of ScienceGoogle Scholar

  • 5.

    Bonaci-Nikolic B, Jeremic I, Nikolic M, Andrejevic S, Lavadinovic L. High procalcitonin in a patient with drug hypersensitivity syndrome. Inter Med 2009;48:1471–4.CrossrefGoogle Scholar

  • 6.

    Cantarin-Extremera V, Castano-De La Mota C, Alvarez-Coca J, Rojas MR, Gutierrez-Solana LG, Garcia Penas JJ, et al. Procalcitonin, a high acute phase reactant in antiepileptic hypersensitivity syndrome in pediatric age. Eur J Paediatr Neurol 2012;16:200–2.CrossrefGoogle Scholar

  • 7.

    Matwiyoff GN, Prahl JD, Miller RJ, Carmichael JJ, Amundson DE, Seda G, et al. Immune regulation of procalcitonin: a biomarker and mediator of infection. Inflamm Res 2012;61:401–9.Web of ScienceGoogle Scholar

  • 8.

    Stone SF, Cotterell C, Isbister GK, Holdgate A, Brown SG. Elevated serum cytokines during human anaphylaxis: identification of potential mediators of acute allergic reactions. J Allergy Clin Immunol 2009;124:786–92.Web of ScienceGoogle Scholar

  • 9.

    Jäger U, Fridrik M, Zeitlinger M, Heintel, D, Hopfinger G, Burgstaller S, et al. Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response. Haematologica 2012;97:1431–8.Web of ScienceGoogle Scholar

  • 10.

    Mann J, Cavallazzi R. Marked serum procalcitonin level in response to isolated anaphylactic shock. Am J Emerg Med 2015;33:125.e5–6.Web of ScienceGoogle Scholar

About the article

Corresponding author: Christoph Robier, MD, Central Laboratory, Hospital of the Brothers of St. John of God, Graz, Bergstr. 27, 8020 Graz, Austria, Phone: +43 316 5989 6671, Fax +43 316 5989 1505, E-mail: ; and Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria


Received: 2015-08-10

Accepted: 2015-08-29

Published Online: 2015-09-19

Published in Print: 2016-03-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 54, Issue 3, Pages e101–e103, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2015-0772.

Export Citation

©2016 by De Gruyter.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
David N. Gilbert
Infectious Disease Clinics of North America, 2017, Volume 31, Number 3, Page 435
[2]
Henry D. Lather and J. Michelle Kahlenberg
Case Reports in Rheumatology, 2016, Volume 2016, Page 1
[3]
Reactions Weekly, 2016, Volume 1594, Number 1, Page 180

Comments (0)

Please log in or register to comment.
Log in